Black patients more likely to be excluded from pancreatic cancer

By A Mystery Man Writer

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era - Advances in Radiation Oncology

Researchers Report on Very Rare, Aggressive Subtype of Pancreatic Cancer

AACI Update

CEUS helps rule out pancreatic cancer - International Contrast Ultrasound Society

NCI trials for April 2022 - The Cancer Letter

Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

JCM, Free Full-Text

Albert Einstein Cancer Center appoints Ulrich Steidl, Adebola Adedimeji, H. Dean Hosgood to leadership positions - The Cancer Letter

©2016-2024, doctommy.com, Inc. or its affiliates